Piper Sandler analyst Arvind Ramnani downgrades Thoughtworks Holding (NASDAQ:TWKS) from Overweight to Neutral and lowers the price target from $14 to $9.5.
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
JP Morgan has decided to maintain its Overweight rating of Thoughtworks Holding (NASDAQ:TWKS) and lower its price target from $20.00 to $16.00.
Shares of Thoughtworks Holding are trading down 1.58% over the last 24 hours, at $9.32 per share.
Over the past 3 months, 8 analysts have published their opinion on Thoughtworks Holding (NASDAQ:TWKS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.